Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Chih-Chung Tseng"'
Publikováno v:
Encyclopedia of Reagents for Organic Synthesis
Autor:
Matteo Zanda, Sergio Dall'Angelo, Giulia Donvito, Aron H. Lichtman, Chiara Zanato, Iain R. Greig, Sophie E. Juola, Mohammed A. Mustafa, Ruth A. Ross, Gemma L. Baillie, Chih-Chung Tseng, William T. A. Harrison, Chiara Massarenti
Publikováno v:
J Med Chem
Journal of medicinal chemistry 62 (2019): 5049–5062. doi:10.1021/acs.jmedchem.9b00252
info:cnr-pdr/source/autori:Tseng C.-C.; Baillie G.; Donvito G.; Mustafa M.A.; Juola S.E.; Zanato C.; Massarenti C.; Dall'Angelo S.; Harrison W.T.A.; Lichtman A.H.; Ross R.A.; Zanda M.; Greig I.R./titolo:The Trifluoromethyl Group as a Bioisosteric Replacement of the Aliphatic Nitro Group in CB1 Receptor Positive Allosteric Modulators/doi:10.1021%2Facs.jmedchem.9b00252/rivista:Journal of medicinal chemistry/anno:2019/pagina_da:5049/pagina_a:5062/intervallo_pagine:5049–5062/volume:62
Journal of medicinal chemistry 62 (2019): 5049–5062. doi:10.1021/acs.jmedchem.9b00252
info:cnr-pdr/source/autori:Tseng C.-C.; Baillie G.; Donvito G.; Mustafa M.A.; Juola S.E.; Zanato C.; Massarenti C.; Dall'Angelo S.; Harrison W.T.A.; Lichtman A.H.; Ross R.A.; Zanda M.; Greig I.R./titolo:The Trifluoromethyl Group as a Bioisosteric Replacement of the Aliphatic Nitro Group in CB1 Receptor Positive Allosteric Modulators/doi:10.1021%2Facs.jmedchem.9b00252/rivista:Journal of medicinal chemistry/anno:2019/pagina_da:5049/pagina_a:5062/intervallo_pagine:5049–5062/volume:62
The first generation of CB(1) positive allosteric modulators (e.g., ZCZ011) featured a 3-nitroalkyl-2-phenyl-indole structure. Although a small number of drugs include the nitro group, it is generally not regarded as being “drug-like”, and this i
Publikováno v:
Magma (New York, N.y.)
Purpose Glycogen synthase kinase 3 (GSK3) is a key controlling element of many cellular processes including cell-cycle progression and recent studies suggest that GSK3 is a potential anticancer target. Changes in glucose metabolism associated with GS
Autor:
James W. Janetka, Amarendar Reddy Maddirala, Paul J. Brindley, Judy A. Sakanari, Jonathan D.M. Helander, Iain R. Greig, Scott A. Wildman, Rahul Tyagi, Chih-Chung Tseng, Christina A. Bulman, Mostafa A. Elfawal, Bruce A. Rosa, Makedonka Mitreva, Chelsea Fischer, Xin Gao, Raffi V. Aroian, Mingzhou Zhou, Ryan Chugani
Publikováno v:
ACS Infectious Diseases. 4:1130-1145
The enormous prevalence of infections caused by parasitic nematodes worldwide, coupled to the rapid emergence of their resistance to commonly used anthelmintic drugs, presents an urgent need for the discovery of new drugs. Herein, we have identified
Autor:
Monica Sani, Denis M. Grant, Hannah Noordali, Iain R. Greig, Michael P. Frenneaux, Chih-Chung Tseng, Matteo Zanda, Melanie Madhani
Publikováno v:
Journal of medicinal chemistry 60 (2017): 2780–2789. doi:10.1021/acs.jmedchem.6b01592
info:cnr-pdr/source/autori:Tseng C.-C.; Noordali H.; Sani M.; Madhani M.; Grant D.M.; Frenneaux M.P.; Zanda M.; Greig I.R./titolo:Development of Fluorinated Analogues of Perhexiline with Improved Pharmacokinetic Properties and Retained Efficacy/doi:10.1021%2Facs.jmedchem.6b01592/rivista:Journal of medicinal chemistry/anno:2017/pagina_da:2780/pagina_a:2789/intervallo_pagine:2780–2789/volume:60
info:cnr-pdr/source/autori:Tseng C.-C.; Noordali H.; Sani M.; Madhani M.; Grant D.M.; Frenneaux M.P.; Zanda M.; Greig I.R./titolo:Development of Fluorinated Analogues of Perhexiline with Improved Pharmacokinetic Properties and Retained Efficacy/doi:10.1021%2Facs.jmedchem.6b01592/rivista:Journal of medicinal chemistry/anno:2017/pagina_da:2780/pagina_a:2789/intervallo_pagine:2780–2789/volume:60
We designed and synthesized perhexiline analogues that have the same therapeutic profile as the parent cardiovascular drug but lacking its metabolic liability associated with CYP2D6 metabolism. Cycloalkyl perhexiline analogues 6a-j were found to be u
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2017 (2017)
BioMed Research International, Vol 2017 (2017)
Androgen receptor (AR) activation is the primary driving factor in prostate cancer which is initially responsive to castration but then becomes resistant (castration-resistant prostate cancer (CRPC)). CRPC cells still retain the functioning AR which
Publikováno v:
Angewandte Chemie International Edition. 52:13256-13260
As a novel class of polyketides, indoxamycins A–F were isolated in 2009 by Sato et al. from saline cultures of marinederived actinomycetes. Within this family, indoxamycins A and F have exhibited promising growth-inhibition activity against HT-29 t
Autor:
Gemma L. Baillie, Simona Frau, Paolo Lazzari, Matteo Zanda, Chih-Chung Tseng, Marilena Pira, Ruth A. Ross, Sergio Dall'Angelo
Publikováno v:
Journal of fluorine chemistry
152 (2013): 166–172. doi:10.1016/j.jfluchem.2013.03.006
info:cnr-pdr/source/autori:Frau, Simona; Dall'Angelo, Sergio; Baillie, Gemma L.; Ross, Ruth A.; Pira, Marilena; Tseng, Chih-Chung; Lazzari, Paolo; Zanda, Matteo/titolo:Pyrazole-type cannabinoid ligands conjugated with fluoro-deoxy-carbohydrates as potential PET-imaging agents: Synthesis and CB1%2FCB2 receptor affinity evaluation/doi:10.1016%2Fj.jfluchem.2013.03.006/rivista:Journal of fluorine chemistry (Print)/anno:2013/pagina_da:166/pagina_a:172/intervallo_pagine:166–172/volume:152
152 (2013): 166–172. doi:10.1016/j.jfluchem.2013.03.006
info:cnr-pdr/source/autori:Frau, Simona; Dall'Angelo, Sergio; Baillie, Gemma L.; Ross, Ruth A.; Pira, Marilena; Tseng, Chih-Chung; Lazzari, Paolo; Zanda, Matteo/titolo:Pyrazole-type cannabinoid ligands conjugated with fluoro-deoxy-carbohydrates as potential PET-imaging agents: Synthesis and CB1%2FCB2 receptor affinity evaluation/doi:10.1016%2Fj.jfluchem.2013.03.006/rivista:Journal of fluorine chemistry (Print)/anno:2013/pagina_da:166/pagina_a:172/intervallo_pagine:166–172/volume:152
A novel class of cannabinoid ligands was synthesized in good overall yields by means of oxime-bio-conjugation between hydroxylamine-functionalized Rimonabant-type pyrazoles and fluoro-deoxy-carbohydrates (D-2-fluoro-deoxy-glucose, FDG, and D-5-fluoro
Publikováno v:
Scientific Reports.
Akt is an intracellular signalling pathway that serves as an essential link between cell surface receptors and cellular processes including proliferation, development and survival. The pathway has many downstream targets including glycogen synthase k
Publikováno v:
ChemInform. 47
We gratefully thank Signal Pharma for financial support and fellowship (C.C.T), and the EPSRC National Mass Spectrometry Service Centre (Swansea, UK) for performing HRMS analyses. We thank Prof Michael Frenneaux (University of East Anglia, Norwich, U